Briana C. Prager

Harvard University — United States

Medicine · Health Sciences

33h-index6.7kcitations167works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(28), RNA modifications and cancer(27), 3D Printing in Biomedical Research(23), Cancer-related molecular mechanisms research(19), Cancer, Hypoxia, and Metabolism(18)

Publications167 total

Immunotherapy and targeted therapy for high grade gliomas: current and future directions
Journal of Neuro-Oncology·2025
Multi-Institutional Assessment of Circulating Cell-Free DNA in Cerebrospinal Fluid Facilitates Central Nervous System Lymphoma Diagnosis and Treatment Initiation
Neurosurgery·2025
Correction: Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma
The Journal of Experimental Medicine·2025Open Access
203 RNA Polymerase II Meningioma Mutations Activate Forebrain Neurodevelopmental Pathways
Neurosurgery·2024
Gα12 signaling regulates transcriptional and phenotypic responses that promote glioblastoma tumor invasion
Scientific Reports·2023· 6 citedOpen Access
LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2’-O-methylation
Nature Communications·2023· 34 citedOpen Access
EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma
Molecular Cell·2023· 51 citedOpen Access
Editorial: Epigenetic and metabolic regulation of primary and metastatic brain cancers
Frontiers in Oncology·2023Open Access
Table S2 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S1 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S2 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Data from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Data from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S4 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S1 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Supplementary Figures and Legends from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S3 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Supplementary Figures and Legends from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S4 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S3 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Jeremy N. Rich(46), Qiulian Wu(28), Ryan C. Gimple(28), Xiuxing Wang(21), Leo J.Y. Kim(17), Qi Xie(16), Shideng Bao(16), Stephen C. Mack(15), Zhixin Qiu(15), Zhe Zhu(14), Christopher G. Hubert(11), Deobrat Dixit(9), Tyler E. Miller(9), Zhen Dong(8), Guoxin Zhang(8), Andrew E. Sloan(7), Andrew R. Morton(7), Wenchao Zhou(7), Linjie Zhao(7), Deguan Lv(7)